New regimens boost optimism for pancreatic cancer

Stereotactic ablative radiation (SABR) allowed 40% of patients with inoperable pancreatic cancer to proceed to surgery, which left no residual disease in 92% of cases, interim results from a small clinical study showed.

MedPage Today